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C ore facilities and research infrastruc-tures have become an essential partof the scientific ecosystem. In the field
of proteomics, national and international
networks and research platforms have been
established during the past decade that are
supposed to set standards for high-quality
services, promote an exchange of professional
information, and enable access to cutting-
edge, specialized proteomics technologies.
Either centralized or distributed, these national
and international proteomics infrastructures
and technology platforms are generating
massive amounts of data for the research
community, and support a broad range of
translational, computational and multi-omics
initiatives and basic research projects.
By delegating part of their work to these
services, researchers expect that the core
facility adjusts their analytical protocols
appropriately for their project to acquire data
conforming best research practice of the
scientific community. The implementation of
quality assessment measures and commonly
accepted quality controls in data generation
is therefore crucially important for proteo-
mics research infrastructures and the scien-
tists who rely on them.
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However, current quality control and
quality assessment procedures in proteomics
core facilities and research infrastructures are
a motley collection of protocols, standards,
reference compounds and software tools.
Proteomics relies on a customized multi-step
workflow typically consisting of sample
preparation, data acquisition and data process-
ing, and the implementation of each step dif-
fers among facilities. For example, sample
preparation involves enzymatic digestion of
the proteins, which can be performed in-
solution, in-gel, or on-beads, with often dif-
ferent proteolytic enzymes, chemicals, and
conditions among laboratories. Data acquisi-
tion protocols are often customized to the
particular instrument set up, and the acquired
spectra and chromatograms are processed by
different software tools provided by equipment
vendors, third parties or developed in-house.
Moreover, core facilities implement their
own guidelines to monitor the performance
and quality of the entire workflow, typically
utilizing different commercially available
standards such as pre-digested cell lysates,
recombinant proteins, protein mixtures, or
isotopically labeled peptides. Currently, there
is no clear consensus on if, when and how to
perform quality control checks. There is even
less quality control in walk-in facilities,
where the staff is only responsible for correct
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usage of the instruments and users select and
execute the analytical workflow themselves.
It is not surprising therefore that instrument
stability and robustness of the applied analyt-
ical approach are often unclear, which
compromises analytical rigor.
Establishing standardized practices
Initiated by the HUPO Proteomics Standard
Initiative (PSI) more than a decade ago, MIAPE
guidelines (Minimal Information about Proteo-
mics Experiment; Taylor et al, 2007) introduced
common formats for sharing and reporting
proteomics data, including unrestricted access
to raw data at public repositories (Vizcaıno
et al, 2014). Supported by journals’ guidelines
that request the deposition of raw data into
such repositories as a condition for publica-
tion, these repositories have grown into a
rich resource for data mining and multi-
omics integration. However, MIAPE guideli-
nes did not imply quality metrics and there is
still no generic tool capable of independently
ascertaining the technical quality of the
deposited data. The importance of quality
assessments for open-access proteomics was
highlighted in the Amsterdam Principles more
than 10 years ago (Rodriguez et al, 2009),
but the development of quality threshold
metrics was delegated to central repositories.
......................................................
“A recent comprehensive
survey among research facili-
ties across Europe showed that
the majority of core facilities do
recognize the need and impor-
tance of quality controls.”
......................................................
A few years later, the Sydney workshop
convened by the US National Cancer Insti-
tute made recommendations and formulated
key principles for data quality metrics, and
journal editors and reviewers were supposed
to encourage or enforce their implementa-
tion in practice (Kinsinger et al, 2012). The
corollary recognized “the need for formal
comparison of methods on equal footing”
thus alluding for the first time to a common
quality control. More recently, recommenda-
tions for quality control metrics have indeed
been included in publishing guidelines
(Abbatiello et al, 2017).
The need for common quality assessment
protocols in scientific infrastructures has
also been emphasized by international
research associations. The Association of
Biomolecular Research Facilities (ABRF), Core
Technologies for Life Sciences (CTLS), Core
for Life (C4L), and the Clinical Proteomic
Tumor Analysis Consortium (CPTAC), initi-
ated discussions and development of common
quality procedures, and continuously promote
sharing of best practices. A recent compre-
hensive survey among research facilities
across Europe showed that the majority of
core facilities do recognize the need and
importance of quality controls (Kos-Braun
et al, 2020). However, we believe that the
issue of systematic quality procedures in
proteomics infrastructures still has not
received the public attention it deserves.
Moreover, we maintain that community
efforts toward quality control and quality
assessment are not sufficiently organized to
achieve systematic agreement, despite the
availability of methods for the evaluation of
analytical protocols, intra- and inter-laboratory
comparison of reproducibility, and software
tools for automated monitoring of instru-
ment performance.
......................................................
“Core facilities and research
infrastructures are technology
hubs and their operations are




Common quality control procedures
Common quality control procedures in
proteomics core facilities ensure technical
quality, reproducibility, comparability, and
data integrity. A representative example of
how these benefit the coordinated work of
several proteomics units is the dissection
and validation of a SARS protein interaction
map (Gordon et al, 2020). Common quality
controls foster reuse of resources, protect
against bias in experimental design and
improve daily routines (Fig 1). Systematic
assessment of instrument performance, early
recognition of poor-quality data, and moni-
toring carry-over and background signals
enable long-term robustness and repro-
ducibility of the proteomics workflow and
leverage the impact of aging instruments or
turnaround of the laboratory staff.
Quality control procedures should be
generic and flexible and support diverse
workflows and instrumental platforms. Core
facilities and research infrastructures are
technology hubs and their operations are not,
and should not, be limited to routine analyti-
cal measurements. Diversity of model organ-
isms, scales, and research goals of the scientific
community generate numerous project-specific
protocols and great variability of workflows.
Instrumentation platforms and analytical
software will also remain diverse and hetero-
geneous in the foreseeable future. The choice
of mass spectrometry equipment is often not
only defined by scientific requirements but
also influenced by the availability of funding
and results in a collection of instruments of
different generations, types, and vendors
within the same facility.
Quality procedures should be therefore
organized into a framework that accommo-
dates these diverse workflows and instru-
mental platforms. Such a framework should
rely on common commercially available
protein and peptide standards that—alone or
spiked into the samples—are systematically
analyzed for values relevant for quality
control, such as the number identified of
proteins, retention time and intensity of the
peptide chromatographic peaks, ratio, or
fold change of endogenous and isotopically
labeled reference peptides. These repeated
test runs would document the analytical
performance of the entire workflow applied
to an individual sample or sample batch.
The information would be highly valuable
for detecting random failures, monitoring
instrument stability, and ensuring the repro-
ducibility of repeated analyses, but also for
continuous methods optimization and devel-
oping new methods. Moreover, common qual-
ity control parameters should be submitted
to repositories along with the raw result data
as required by MIAPE guidelines.
......................................................
“. . . common quality control
parameters should be submit-
ted to repositories along with
the raw result data as required
by MIAPE guidelines.”
......................................................
The frequent analysis of standard samples
would also help to generate laboratory-based
average references that monitor the perfor-
mance drift of instruments and indicate
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whether the settings applied to analytical and
computational workflow are optimal or
would need readjustment. Such records could
help to diagnose instrument malfunction and
to test the performance of new instruments.
In the future, software tools could be inte-
grated with both instruments and reference
data repositories to streamline the collection
and management of quality control values.
The aforementioned procedures could be a
step towards ISO (International Organization
for Standardization) or other quality certifi-
cations for core facilities and research infras-
tructures that require it.
The role of funders and
technology providers
The development and implementation of
common quality management schemes pose
a challenge for the entire proteomics commu-
nity and require support from technology
providers and funding agencies. The proteo-
mics community must therefore define a
common set of quality parameters, standards,
controlled vocabulary, and generic file
formats to support collective testing and
anonymized evaluation of the results. They
should also work with technology providers
to implement quality checks in vendors’ soft-
ware. Last but not least, the community
should approach national and international
funding bodies to raise awareness of the
importance of common quality control proce-
dure in order to secure their financial
support.
Research infrastructures and core facilities
are in the position to drive initiatives that
require extensive collaboration and concerted
efforts.Within the Core for Life alliance (Meder
et al, 2016; Lippens et al, 2019) (https://coref
orlife.eu), our proteomics laboratories advo-
cate for community policies for quality control
procedures to ensure the high standards in
proteomics services. Among other initiatives,
we have developed and endorsed the QCloud
tool as a cross-platform open-source quality
control software for systematic monitoring of
instrument performance (Chiva et al, 2018;
Olivella et al, 2021). However, there is a
further need in developing automated, user-
friendly, and flexible routines suitable for
inter-laboratory collection of quality data that
satisfy data protection requirements and remain
affordable for the broader research commu-
nity. These and other practical measures
require understanding and support of the
entire proteomics community, funding, and
publishing bodies.
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Figure 1. Benefits of common quality procedures.
Main benefits of the implementation of common quality procedures in proteomics research infrastructures and core facilities for the users and customers, the scientific
community, and the infrastructures themselves.
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